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Abstract
Background: Scoparia dulcis Linn (Scrophulariaceae) together with other medicinal plants serve as antisickling
remedies in Africa. This study was aimed at investigating the antisickling activity of the leaves of the plant as well as
establishing the toxicological profile.
Method: Chemical tests were employed in phytochemical investigations. Evaluation of the antisickling activity
involved the inhibition of sodium metabisulphite-induced sickling of the HbSS red blood cells obtained from
confirmed sickle cell patients who were not in crises. Concentrations of the crude extract and its fractions were
tested with normal saline and p-hydroxybenzoic acid serving as controls. Acute toxicological evaluation was carried
out in mice while 30-day assessment was done in rats.
Results: Phytochemical screening revealed the presence of alkaloids, tannins, flavonoids and saponins. Percentage
sickling inhibitions of the aqueous methanol extracts of S. dulcis were significant all through the period of assay
p < 0. 05 compared to normal saline, but not significant with PHBA. The fractions had less activity compared to the
crude extracts. The LD 50 of the extract in mice was above 8000 mg/kg body weight when administered orally.
Toxicological evaluations at 250 and 500 mg/kg showed mild congestion in virtually all the target organs.
Conclusion: The antisickling results confirmed traditional usage of Scoparia dulcis in the management of Sickle cell
disorders and a candidate for further investigations.
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Background
Scoparia dulcis Linn belongs to the Scrophulariaceae
family. Common names include goatweed [1], scoparia
weed, sweet broom in English, tape cava, tapixaba, vas-
sourintia in Portuguese and escobillo in Spanish [2]. It is
also known as roma fada in Hausa and aiya in Ibo [3]. It
is native to the Neotropics, but it can be found through-
out the tropical and subtropical world. Ethnomedicinally,
S. dulcis is used to manage sickle cell disease in Nigeria
[4], used for anaemia, burns, headache in Nicaragua [5],
used to treat diabetes in India and hypertension in
Taiwan [6] and also for bronchitis [7].
The diterpenoid Scoparinal, isolated from the plant
demonstrated significant analgesic and anti-inflammatory
activities (P < 0.001) in animals [8]. Scopadulcic acid B
inhibited TPA-enhanced phospholipid synthesis in culti-
vated cells and inhibited the effect of TPA on skin tumor
formulated in mice initiated with 7, 12 dimethylbenzyl
anthracene [9]. The acetylated flavones glycosides of S.
dulcis have NGR-potentiating activity which may be useful
in treating neurological disorders [10]. High Performance
Liquid Chromatography (HPLC) analysis of the aqueous
fraction of S. dulcis revealed the presence of noradrenalins
and adrenaline which had sympathomimetric effects [11].
Sickle Cell Disease (SCD) is one of the most prevalent
morbidity and mortality diseases in Africa [12], but it
also affects persons of Mediterranean, Caribbean, South
and Central American, Arab and East Indian origins
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[13]. In Nigeria, the most common type of SCD is the
homozygous (HbSS) form i.e. SCA. Estimates show that
25 % of the Nigerian population are “carriers” of the
Sickle cell trait i.e. HbAS [14]. SCD is a genetic blood
disorder characterized by red blood cells (RBC) that as-
sume an abnormal rigid sickled shape. The disease stems
from inadequate oxygen transport by red blood cells. In
vivo, sickled erythrocytes tend to block capillaries, causing
stasis, and thereby starve organs of nutrients and oxygen,
eventually causing hypofunction and complete tissue de-
struction [15]. Sickling decreases the RBC’s flexibility
and results in risk of various complications such as
chronic renal failure [16], retinopathy [17], pulmonary
hypertension [18], chronic pain [19], ischemia [20],
stroke [21], priapsm and infraction of the penis [22].
Management of sickle cell is aimed at relieving pain,
preventing infections and management of complica-
tions. First line clinical management of sickle cell an-
aemia includes use of hydroxyurea, folic acid, amino
acids and blood transfusion to stabilize the patient’s
haemoglobin level [23]. These are quite expensive and
have attendant risk factors, thereby gradually paving
way for the consideration of condiments from natural
sources as antisickling remedies [24]. The increasing
interest in these condiments is not unconnected with
the general innocuous nature of their sources, which
most often are herbs and even at times food crops.
Researches into antisickling properties of medicinal
plants have been rewarding. This alternative therapy
using phytomedicines has proven to not only reduce
crises but also reverse sickling. Attempts to find alter-
native, cheaper, and less toxic therapies led to the
scientific discovery of antisickling properties of some
medicinal plants such as Cajanus cajan seeds,
Zanthoxylum zanthoxyloides (Fagara) root, Carica pa-
paya unripe fruit, and also Parquetina nigrescens
whole plant extracts which boost blood volume – all
these are locally used by traditional healers in Nigeria
for diverse herbal remedies [23]. This study was
designed to investigate the antisickling activity as well
as the toxicological profile of Scoparia dulcis Linn
(Euphorbiaceae), one of the recipes which have been
used with acclaimed success by traditional healers in
Nigeria in managing sickle cell anaemia.
Methods
Collection of plant
The leaves of Scoparia dulcis Linn (Euphorbiaceae) were
collected in Benin City, Edo State, Nigeria. The plants
were authenticated by the curator at the Herbarium of
the Department of Pharmacognosy, Faculty of Pharmacy,
University of Benin, Benin City where a voucher speci-
men was deposited.
Animals
Swiss albino mice (25. 92 ± 1. 05 g) and Wistar rats (220.
00 ± 16. 44 g) of both sexes were obtained from the Ani-
mal House, Department of Pharmacology and Toxicology,
Faculty of Pharmacy, University of Benin, Benin City. All
the animals were kept under standard environmental con-
ditions and were handled according to international
protocol for use of animals in experiments [25]. They were
fed with standard pellets and tap water ad libitum. Ethical
approval for the study was obtained from the College of
Medicine, University of Benin Animal Ethics Committee
(ADM/F. 22A/Vol. viii/349).
Phytochemical investigation
Chemical tests were employed in the preliminary phyto-
chemical screening for various secondary metabolites such
as tannins (phenazone; iron complex; formaldehyde and
modified iron complex tests were carried out on the aque-
ous extract to detect the presence of hydrolysable, con-
densed and pseudo tannins); cardiac glycosides (Keller -
Killiani and Kedde tests were carried out on the methanolic
extract to detect the presence of a deoxy sugar and to indi-
cate the presence of a lactone ring on the cardenolides
respectively); alkaloids (Mayer’s, Dragendorff ’s, Wagner’s
and 1 % picric acid reagents to detect the presence of alka-
loidal salts and bases), saponins glycosides (frothing of the
aqueous extract when shaken and haemolysis test on blood
agar plates were carried out to indicate and confirm the
presence of saponins); anthracene derivatives (Borntrager’s
test for combined and free anthraquinones, where agly-
cones were extracted using chloroform and shaken with di-
lute ammonia) and cyanogenetic glycosides (sodium picrate
paper test were used to test for the presence of hydrocyanic
acid in the sample. Conversion to sodium isopurpurate in-
dicates the presence of cyanogenetic glycosides) [26, 27].
Extraction and fractionation
The fresh leaves of Scoparia dulcis Linn were air–
dried for 72 h and powdered using an electric mill.
The powdered leaves (4.2 kg) were extracted with
MeOH-H2O (50: 50) (5 × 2 L). Evaporating the solvent
on a water bath yielded an extract (0.78 kg) which was
subsequently re-suspended in water and successively
partitioned into petroleum ether (3 × 2 L), chloroform
(3 × 2 L) and n-butanol (3 × 2 L). The fractions were




HbSS Blood samples were collected by venipuncture
from confirmed sickle cell patients not in crises on their
clinic days at the Consultant Outpatient Department
(COPD) of the University Teaching Hospital, Benin City,
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Nigeria. None of the patients used was recently trans-
fused with HbAA blood.
Antisickling activity evaluation
The evaluation of the leaf extract and fractions of
Scoparia dulcis Linn for antisickling activities was car-
ried out using a modified method of Moody and
co-workers [28]. Venipuncture blood samples from sickle
cell anaemia patients not in crises were collected into
EDTA bottles. Collected samples were centrifuged to re-
move the serum. The resulting packed erythrocytes were
washed three times with sterile normal saline and centri-
fuged each time to remove the supernatant. 0.5 ml of
the washed erythrocytes were mixed each with 0.5 ml
of the different concentrations of the aqueous metha-
nol extract (100, 300 and 500 mg/ml) or fractions
(500 mg/ml) in uncovered test tubes. A 5 mg/ml solu-
tion of ρ-hydroxybenzoic acid (PHBA) in normal saline
was used as the positive control while normal saline
served as negative control. Samples were taken from
the different mixtures and the remaining portions of
the mixtures incubated for 3 h, shaking occasionally.
A 2 % Sodium metabisulphite (0.5 ml) was added to
each mixture to deoxygenate the system, mixed thor-
oughly and sealed with liquid paraffin. Samples were
taken in five replicates from the different mixtures at
0 min and at subsequent 30 min interval until seven
readings were obtained.
Each sample was smeared on a microscopic slide, fixed
with 95 % methanol, dried and stained with giemsa stain.
Each slide was examined under the oil immersion light
microscope and counting of 100 red cells in each sam-
ple. The numbers of both sickled and unsickled red blood
cells were counted and the percentage of unsickled cells
determined.
Toxicological evaluation
Swiss albino mice, divided into 6 groups of 5 animals per
group were orally administered the extract at doses of
1000, 2000, 3000, 4000, 5000, 6000, 7000 and 8000 mg/kg.
The control group received only the vehicle (normal saline
5 ml/kg). Each group of mice was placed in the test cage
for a 30–min habituation period before drug administra-
tion. The animals were observed for 10 min for the first
6 h and 10 min each day for the next two days. Lethality
and gross toxicological features (convulsion, diarrhea,
hyperactivity and pile-erection) were recorded for each
group [29]. The animals were further observed for four-
teen days.
Thirty Wistar rats were randomly distributed into three
groups of ten rats each. The first (A) group served as con-
trol and received 5 ml/kg of normal saline (vehicle) while
the second (B) and third (C) groups received oral doses of
250 and 500 mg/kg per day of the extract respectively for
30 consecutive days. The animals were observed for signs
of toxicity (abnormal behaviours, writhing, convulsion,
mood, motor activity and general body conditions) for
30 min each day. At the end of 30 days, the rats were
sacrificed under chloroform anesthesia. Livers, lungs,
hearts and testis were removed and preserved in 10 % for-
maldehyde solution. Each organ was sectioned (6 μ thick)
embedded in paraffin wax and stained with hematoxylin
and eosin [30].
Statistical analysis
Data are expressed as mean ± SEM. The differences be-
tween the means were analyzed using one way analysis
of variance (ANOVA). Values of P < 0.05 were taken to
imply statistical significance between compared data.
Results
Phytochemical screening
Phytochemical screening of the leaves of S. dulcis re-
vealed the presence of tannins, flavonoids, saponins and
alkaloids (Table 1).
Sickling inhibitory activities of crude extracts and
fractions of S. dulcis
Percentage sickling inhibition of the various doses of S.
dulcis extracts were significant all through the period of
assay (p < 0. 05) (Table 2). There was no significant dif-
ference between the antisickling activity exhibited at 100
and 300 mg/ml. The petroleum ether and n-butanol
fractions were devoid of inhibitory activities.
Toxicological evaluation
The aqueous extract of S. dulcis did not produce any mor-
tality up to the oral dose level of 8 g/kg body weight in
mice. There were no changes in behaviour, posture, nature
and frequency of stooling, mood and motor activity. The
animals did not convulse, exhibit writhing or die.
Daily administration of the extract for 30 days did not
produce gross toxicological symptoms or deaths. Histo-
pathology of the heart (Figs. 1 and 2) and liver (Figs. 3
and 4) showed mild vascular and portal congestions
Table 1 Phytochemical constituents of S. dulcis leaves









- = absent; + = present
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respectively. There was no degeneration of tissues in the
lungs (Figs. 5 and 6) and testis (Figs. 7 and 8) at both
doses except for mild interstitial congestions.
Discussion
The Pharmacological activities of a given medicinal plant
are associated with the type and nature of secondary
plant metabolites present. Phytochemical evaluation of
the leaves of S. dulcis revealed the presence of tannins,
flavonoids, saponins and alkaloids. These compounds
detected in S. dulcis are known to possess medicinal
properties and health promoting effects [31]. Previous
investigations have attributed the antisickling activity of
many medicinal plants used in the management of sickle
cell diseases to their inherent phytochemicals. Saponins
and flavonoids present in Hymenocardia acida leaves
were responsible for its antisickling activity [32]. Simi-
larly, anthraquinones, steroidal and cardiac glycosides
present in Cissus populnea L. contributed to the anti-
sickling properties of Ajawaron, an herbal product that
is marketed in Nigeria [28].
Table 2 The sickling inhibitory activities of Scoparia dulcis crude extracts and fractions
Time of incubation (min) Percentage inhibition (%)
A* B** C D E F G H I
0 time before incubation 59.2 ± 0.12 79.0 ± 0.22 59.8 ± 1.04 58.2 ± 0.52 60.0 ± 1.34 36.4 ± 0.68 58.0 ± 0.81 30.6 ± 0.72 57.0 ± 0.50
30 50.2 ± 0.31 76.2 ± 0.05 48.0 ± 0.08 55.2 ± 1.17 60.0 ± 0.66 29.0 ± 1.87 58.2 ± 0.86 35.2 ± 1.20 58.0 ± 1.92
60 49.0 ± 0.64 77.0 ± 1.31 54.2 ± 0.12 57.0 ± 0.82 66.2 ± 1.24 28.0 ± 0.66 59.0 ± 1.34 30.2 ± 1.35 56.0 ± 0.04
90 43.4 ± 0.27 73.0 ± 0.67 49.4 ± 1.65 55.4 ± 0.29 69.0 ± 0.95 20.2 ± 1.52 60.6 ± 1.10 31.2 ± 0.07 50.4 ± 1.66
120 43.2 ± 0.32 76.0 ± 0.04 59.0 ± 1.04 60.0 ± 1.06 75.2 ± 0.73 29.8 ± 1.34 58.0 ± 0.26 28.0 ± 1.32 45.4 ± 0.47
150 40.4 ± 0.41 69.2 ± 1.18 50.6 ± 0.06 52.0 ± 1.44 55.0 ± 1.42 28.0 ± 0.56 48.0 ± 1.05 20.0 ± 0.45 43.0 ± 1.40
180 39.0 ± 0.52 65.4 ± 1.06 50.0 ± 0.82 50.2 ± 0.85 52.4 ± 0.54 25.2 ± 1.47 45.0 ± 1.12 21.4 ± 0.73 43.0 ± 1.33
Key:
A = blood + Normal saline + Sodium metabisulphite
B = blood + PHBA + Sodium metabisulphite
C = blood + Crude extract of S. dulcis leaf at 100 mg/ml + Sodium metabisulphite
D = blood + Crude extract of S. dulcis leaf at 300 mg/ml + Sodium metabisulphite
E = blood + Crude extract of S. dulcis leaf at 500 mg/ml + Sodium metabisulphite
F = blood + Petroleum ether fraction + Sodium metabisulphite
G = blood + Chloroform fraction + Sodium metabisulphite
H = blood + N-butanol fraction + Sodium metabisulphite
I = blood + Aqueous fraction + Sodium metabisulphite
Percentage sickling inhibitions of the aqueous methanol extracts of S. dulcis were significant all through the period of assay P < 0. 05 compared to normal saline*,
but not with PHBA**
Fig. 1 Photomicrograph of the heart of rats administered with
250 mg/kg extract of S. dulcis for 30 days showing mild vascular
congestion A (H&E × 400)
Fig. 2 Photomicrograph of the heart of rats administered with
500 mg/kg extract of S. dulcis for 30 days showing mild vascular
congestion B (H&E × 400)
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The in-vitro techque adopted in the antisickling effi-
cacy bioassay was based on the simulation of the major
in-vivo sickling-precipitating factor (i.e. reduction of
oxygen tension), using sodium metabisulphite as a
physiologically acceptable reducing agent. Complete
sickling of the sickle cell blood sample was brought
about by the use of sodium metabisulpite solution
(2%w/v) which helped to suck up oxygen from the red
blood cell thus created a state of reduced oxygen tension
which mimics the events that occurs during sickle cell
crisis. This causes the cell to assume characteristic sickle
cell shapes such as the crescent, holly leaf and spindle
shapes. The use of erythrocyte suspension instead of
whole blood was particularly essential in ruling out the
possibility of interactions of plasma component and
products of their several immunological reactions and
certain metabolic co-factors in general with the red
blood cells [14]. Such interactions could significantly
affect the shape and size of red blood cells and in the
process inadvertently produce false negative or false
positive results.
Aqueous and ethanol extracts of several phytomedi-
cines have been evaluated for in vitro antisickling activ-
ity. Recent studies support some of the claims of
traditional healers and suggest a possible correlation be-
tween the chemical composition of these plants and
their uses in traditional medicine [33]. The aqueous
Fig. 3 Photomicrograph of the liver of rats administered with
250 mg/kg extract of S. dulcis for 30 days showing mild vascular
congestion C (H&E × 400)
Fig. 4 Photomicrograph of the liver of rats administered with
500 mg/kg extract of S. dulcis for 30 days showing mild portal
congestion D (H&E × 400)
Fig. 5 Photomicrograph of the lung of rats administered with
250 mg/kg extract of S. dulcis for 30 days showing unremarkable
alveoli E (H&E × 400)
Fig. 6 Photomicrograph of the lung of rats administered with
500 mg/kg extract of S. dulcis for 30 days showing mild interstitial
congestion F (H&E × 400)
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methanol extracts of S. dulcis showed significant inhibi-
tory effects at the concentrations (100, 300 and 500 mg/
ml) on sodium metabisulphite-induced sickling. The
chloroform and aqueous fractions of the crude extract
also inhibited sodium metabisulphite induced sickling of
the HbSS red blood cells to varying degrees. The inhibi-
tory activity of S. dulcis could be due to the presence of
bioactive compounds. The antisickling activity could be
linked to the ability of the bioactive compounds present
in S. dulcis to either inhibit in vitro polymerization of
haemoglobin or to some structural modification linked
to the environment of haemoglobin by the extracts and
fractions [34].
Toxicological studies for all herbal medicines includ-
ing the determination of their median lethal dose (LD
50) and other such parameters essential for a proper
dosage are desirable and necessary. If there is the sus-
pected need for more detailed studies, such herbal med-
icines may be subjected to sub-acute tests. The general
purpose of the sub-acute toxicity tests is to determine
the organs that are likely to be susceptible to toxicity by
the herbal medicines. Histopathological effects of the
administration of 250 and 500 mg/kg per day of the ex-
tract of S. dulcis to rats showed no evidence of tissue
necrosis on the heart, liver, lung and testis. There were
no marked adverse alterations or degeneration of tissues
since these vital organs showed normal architectures
suggesting no morphological disruptions as compared
with the control group. It is an indication of the low
toxicity of the extract [29], therefore S. dulcis could be
said to be relatively safe.
Conclusion
On the basis of the results obtained from the pharmaco-
logical investigations, it could be said that Scoparia dul-
cis possesses antisickling properties, indicating that it
has a role in the treatment of sickle cell disorders and a
good candidate for further investigations.
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Fig. 7 Photomicrograph of the testis of rats administered with
250 mg/kg extract of S. dulcis for 30 days showing moderate stroma
congestion G (H&E × 400)
Fig. 8 Photomicrograph of the testis of rats administered with
500 mg/kg extract of S. dulcis for 30 days showing moderate stroma
congestion H (H&E × 400)
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